IVA – inventiva s.a. - american depository shares (US:NASDAQ)

News

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
Inventiva reports 2025 Third Quarter Financial Information¹
Inventiva (NASDAQ:IVA) had its price target lowered by analysts at Guggenheim from $13.00 to $11.00. They now have a "buy" rating on the stock.
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com